Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

Share Price is delayed by 15 minutes
Get Live Data
120.50    0.00 (0.00%)
Bid:
118.00
Ask:
123.00
Spread: 5.00 (4.237%)
Market Cap: £72.50m
IGP Live PriceLast checked at - London Stock Exchange

Intraday Intercede Share Chart

Trading Update

3 Mar 2017 07:00

RNS Number : 4066Y
Intercede Group PLC
03 March 2017
 

 

 

 

 

3 March 2017

INTERCEDE GROUP plc

('Intercede', the 'Company' or the 'Group')

 

 Trading Update

 

Following the Company's announcement on 5 January 2017 of the receipt of a record $3.0m order, the order book as of 2 March 2017 indicates that, unless further orders are received that can be recognised as revenue in the current period, the revenue outturn for the financial year ending 31 March 2017 will be approximately £8.0m. A further £2.0m of new orders remain in the current period pipeline which includes US government and defence contractor customers.

The Company is working diligently to close these orders. However, the US Presidential Budget Proposal issued on 27 February 2017 made a commitment to radically increase military and infrastructure expenditure during the term of the new administration. This commitment has raised considerable and unexpected uncertainty for the short term budget allocations across the Company's target customer base in the US.

There remains a risk that a proportion of the outstanding orders forecast for closure in the current period will be delayed into the next financial year. The consequent impact on revenue is likely to result in losses for the year to 31 March 2017 being higher than management expectations. In this case, gross cash balances (excluding £4.5m convertible loan notes) are forecast to be approximately £6.0m as at 31 March 2017.

Intercede believes that the impact of the Presidential Budget will be short term in nature. Cybersecurity remains a vital component of US IT strategy and a Presidential Executive Order on Cybersecurity is expected shortly. Contemporaneously, New York State Cybersecurity Regulations for Financial Services Companies 23 NYCRR 500 became effective on 1 March 2017. In the medium to long term, the regulatory trend towards higher levels of cybersecurity will significantly increase budgets. As a result, it is highly probable that this could produce a step change in the Company's revenue potential within the US government and US regulated financial services markets.

Richard Parris, Chairman & CEO of Intercede, commented

"Following the Presidential Budget Proposal, the Board has taken a conservative view of its immediate pipeline. While we remain confident that these orders will flow to revenue, there can be no certainty that this will occur within the current financial year. This timing issue does not in any way detract from the Board's confidence in the Company's prospects. Intercede is developing products and services which directly address the emerging need for higher levels of cybersecurity. In the next 12 months, European and US regulation will require a range of agencies and organisations to put this in place. Intercede is already well advanced in its plans to benefit from this trend, utilising the £4.5m (net) funds raised in January 2017 to invest in new applications for our leading software and to expand into new markets. Intercede is reducing its dependence on single geographies and sectors which will position the Company well for what promises to be a period of potential growth."

 

 

ENQUIRIES

 

Intercede Group plc Tel. +44 (0)1455 558 111

Richard Parris, Chairman & Chief Executive

Andrew Walker, Finance Director

 

finnCap Tel. +44 (0)20 7220 0500

Stuart Andrews, Corporate Finance

Simon Hicks, Corporate Finance

 

Capital Access Group Tel. +44 (0)203 7633405

Scott Fulton

 

 

About Intercede

Intercede is a software and service company specializing in identity, credential management and secure mobility. Its solutions create a foundation of trust between connected people, devices and apps and combine expertise with innovation to provide world-class cybersecurity. Intercede has been delivering solutions to high profile customers, from the US and UK governments to some of the world's largest corporations, telecommunications providers and information technology firms, for over 20 years. Intercede's product portfolio includes MyID, an identity and credential management system that assigns trusted digital identities to employees citizens and machines. In 2015, Intercede launched MyTAM, enabling trusted applications to be loaded into a mobile device's Trusted Execution Environment (TEE), providing hardware-level security for Android apps. In 2016, Intercede launched RapID, a secure, easy to implement authentication service for mobile apps and cloud services to completely eliminate the need for passwords.

 

For more information visit: www.intercede.com

 

 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSSWFWEFWSEED
Date   Source Headline
15th Sep 20217:00 amRNSMultiple Customers choose to Upgrade MyID
20th Jul 20217:00 amRNSIntercede achieves FIDO2 certification
5th Jul 20217:00 amRNSConnect Partner Programme & Q1 Contract Wins
15th Jun 20218:26 amRNSIssue of Equity
8th Jun 20217:00 amRNSFinal Results
2nd Jun 202110:09 amRNSInvestor Presentation
10th May 20217:00 amRNSShare Incentive Plan
7th Apr 20217:00 amRNSTrading Update & Appointment of Auditor
1st Apr 202110:30 amRNSReceipt of $3.4m Order
10th Mar 20217:00 amRNSShare Incentive Plan
23rd Feb 20217:00 amRNSAmendment to LTIP
22nd Feb 20214:10 pmRNSHolding(s) in Company
16th Feb 20217:00 amRNSCLN Conversion to Equity
12th Feb 20217:00 amRNSHolding(s) in Company
8th Feb 202112:40 pmRNSHolding(s) in Company
4th Feb 20217:00 amRNSCLN Call & Issue of Equity
11th Jan 20217:00 amRNSNew Contract Win
5th Jan 202111:00 amRNSCLN Conversion to Equity
4th Jan 202110:40 amRNSHolding(s) in Company
22nd Dec 20207:00 amRNSNew Contract Win
24th Nov 20207:00 amRNSHalf-year Report
17th Nov 20207:00 amRNSContract Win: Follow-on Purchase Order
12th Nov 20207:00 amRNSInvestor Presentation
8th Oct 20207:01 amRNSIntercede join the FIDO Alliance
8th Oct 20207:00 amRNSTrading Update
16th Sep 20203:40 pmRNSResult of AGM
20th Aug 20207:05 amRNSContract Win - Initial Progress Order
5th Aug 20202:01 pmRNSHolding(s) in Company
30th Jul 20207:00 amRNSContract Win
2nd Jun 20207:00 amRNSFinal Results
12th May 20207:00 amRNSShare Incentive Plan
20th Apr 202010:02 amRNSDirector/PDMR Shareholding
14th Apr 20207:00 amRNSDirector/PDMR Shareholding
7th Apr 20207:00 amRNSTrading Update
3rd Apr 20205:07 pmRNSShare Incentive Plan
31st Mar 20207:00 amRNSReceipt of $4.6m Order
28th Feb 20207:00 amRNSShare Incentive Plan
26th Feb 20209:50 amRNSShare Incentive Plan
25th Feb 20207:00 amRNSShare Incentive Plan
12th Feb 202011:22 amRNSShare Award
25th Nov 20197:00 amRNSHalf-year Report
7th Oct 20197:00 amRNSTrading Update
30th Sep 20197:00 amRNSDirector/PDMR Shareholding
18th Sep 20196:30 pmRNSResult of AGM
16th Sep 20193:56 pmRNSPosting of Annual Report & Notice of AGM
17th Jun 20197:00 amRNSAppointment of Non-Executive Director
5th Jun 20197:00 amRNSFinal Results
8th Apr 20197:00 amRNSSale of Property
2nd Apr 20197:00 amRNSTrading Update
28th Feb 20197:00 amRNSNew Contract Win

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.